Tcr2 Therapeutics (TCRR) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.56
-1.27
-0.97
-0.68

Details

Expected EPS
-0.68
Actual EPS
-1.03
Surprise EPS
-0.35
Surprise Percent
+51.47%

Description

Tcr2 Therapeutics (TCRR) has reported earnings of -1.03 per share for Q1 2023.

0 Comments

Share your thoughts